Sarah Fisher

Sarah van Hellenberg Hubar-Fisher serves as the Chief Executive Officer and a Board Member at Global Surgical Initiatives, driving sustainable access to surgical care in resource-limited settings since September 2024. Concurrently, Sarah holds the position of Managing Director at RePhil Capital and serves on the Supervisory Board of Bioretec Ltd. and nen, where the latter focuses on pain management for children with cancer. Past roles include Venture Partner at Nina Capital and Growth Science Ventures and extensive leadership positions at Johnson & Johnson, where Sarah led global public health financing initiatives and business development efforts. Sarah’s academic credentials include an MBA from Babson College and studies at Saïd Business School, University of Oxford.